Alnylam Pharmaceuticals, Inc. (ALNY) - Earnings & Price History

ALNY: Alnylam Pharmaceuticals, Inc. - 82.02, $7.07B, 1.51 (1.88%)

Sector: Healthcare - Industry: Biotechnology

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. The companys clinical development programs include Patisiran and Revusiran, which are in Phase III clinical trials for the treatment of transthyretin amyloidosis (ATTR); ALN-TTRsc02, an investigational RNAi therapeutic targeting TTR for the treatment of various forms of ATTR amyloidosis; Fitusiran, an investigational RNAi therapeutic that is in Phase I clinical trial for the treatment of hemophilia and rare bleeding disorders; ALN-CC5, which is in Phase I/II clinical trial for the treatment of complement-mediated diseases; and ALN-AS1 for the treatment of hepatic porphyrias. Its product development programs also include ALN-AAT for the treatment of alpha-1 antitrypsin deficiency-associated liver disease; ALN-PCSsc that is in Phase I clinical tr

Past ALNY reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-08AMC-1.3444.9640.6340.9340.9346.540.74%9.85%10.66%1.02M
2016-11-02AMC-1.1431.4135.9536.2231.3836.220.75%-13.28%-12.63%3.37M
2016-08-04AMC-1.2478.4271.0372.1271.6179.021.53%▲8.74%10.40%1.09M
2016-05-02AMC-1.0560.8168.7966.860.0766.99-2.89%-8.97%-11.60%1.82M
2016-02-11AMC-0.9659.6356.9652.3851.5161.75-8.04%13.84%4.69%1.89M
2015-11-09BMO-0.91108.84101.5399.9598.47109.8-1.56%8.89%7.20%1.29M
2015-08-06AMC-0.75106.19119.8711097.1110-8.23%▲-3.46%-11.41%2.89M
2015-05-07AMC-0.66112.79106.63105.56105.01112.93-1.00%6.85%5.78%1.13M
2015-02-12AMC-0.695.5493.87969396.152.27%-0.48%1.78%495.12K
2014-11-05AMCAlnylam Pharma-0.65-0.5892.9188.0189.0386.7593.741.16%4.36%5.57%933.70K
2014-08-07AMCAlnylam Pharma-0.54-0.6358.1556.1154.4553.5458.24-2.96%▲6.80%3.64%617.30K
2014-05-08AMCAlnylam Pharma-1.18-0.3954.3350.2647.6847.4254.57-5.13%13.95%8.10%833.30K
2014-02-13AMCAlnylam Pharma-0.48-0.5178.7281.5681.4675.8383.63-0.12%-3.36%-3.48%764.20K
2013-11-06AMCAlnylam Pharma-0.38-0.4850.9254.9754.9349.0254.99-0.07%-7.30%-7.37%2.27M
2013-08-08AMCAlnylam Pharma-0.34-0.2948.2247.3648.2647.5501.90%▲-0.08%1.82%634.90K
2013-05-06AMC-0.2924.4223.724.7624.25225.884.47%-1.37%3.04%964.07K
2013-02-07AMC-1.4324.8223.8424.4524.4325.772.56%1.51%4.11%1.18M
2012-11-05AMC-0.3116.2116.7316.715.9416.98-0.18%-2.93%-3.11%271.93K
2012-08-06AMCQ2 2012 Alnylam Phar-0.19-0.2518.1818.4417.3916.9518.21-5.69%▲4.54%-1.41%954.80K
2012-05-03AMCQ1 2012 Alnylam Phar-0.36-0.259.7810.2910.399.6910.490.97%-5.87%-4.96%366.20K
2012-02-09AMCQ4 2011 Alnylam Phar-0.32-0.3312.1513.0512.611.7212.79-3.45%-3.57%-6.90%724.40K
2011-11-01AMCQ3 2011 Alnylam Phar-0.35-0.317.787.737.957.68.282.85%-2.14%0.65%263.80K
2011-08-01AMCQ2 2011 Alnylam Phar-0.36-0.339.049.49.399.029.84-0.11%▲-3.73%-3.83%245.40K
2011-05-02AMCQ1 2011 Alnylam Phar-0.3-0.389.86109.939.6210.06-0.70%-0.70%-1.40%626.70K
2011-02-17AMCQ4 2010 Alnylam Phar-0.35-0.1611.379.8710.6710.6711.928.11%6.56%15.20%1.56M
2010-11-03AMCQ3 2010 Alnylam Phar-0.4-0.2313.212.612.812.813.51.59%3.12%4.76%386.60K
2010-08-04AMCQ2 2010 Alnylam Phar-0.3-0.3514.9515.0514.9814.9115.2-0.47%▲-0.20%-0.66%341.10K
2010-05-05AMCQ1 2010 Alnylam Phar-0.3-0.2916.2416.916.8515.217.01-0.30%-3.62%-3.91%487.40K
2010-02-25AMCQ4 2009 Alnylam Phar-0.3-0.1917.4217.9717.9517.218.12-0.11%-2.95%-3.06%218.20K
2009-11-04AMCQ3 2009 Alnylam Phar-0.24-0.2216.4217.4317.0516.3317.05-2.18%-3.70%-5.79%814.50K
2009-08-06AMCQ2 2009 Alnylam Phar-0.49-0.5521.3222.2122.5921.2922.811.71%▲-5.62%-4.01%321.50K
2009-05-07AMCQ1 2009 Alnylam Phar-0.23-0.1919.9618.0618.3718.3320.141.72%8.66%10.52%712.10K
2009-02-24AMCQ4 2008 Alnylam Phar-0.15-0.2320.3920.7920.9719.8621.290.87%-2.77%-1.92%499.50K
2008-11-05AMCQ3 2008 Alnylam Phar-0.17-0.0725.9726.2225.7525.7126.51-1.79%0.85%-0.95%374.70K
2008-08-06AMCQ2 2008 Alnylam Phar-0.15-0.3134.2235.9534.4133.9735.83-4.28%▲-0.55%-4.81%1.06M
2008-05-08Q1 2008 Alnylam Phar-0.14-0.0327.6725.3925.6625.4528.361.06%7.83%8.98%1.14M
2008-02-07AMCQ4 2007 Alnylam Phar-0.220.0431.6830.3332.9431.5833.598.61%-3.83%4.45%1.08M
2007-11-01AMCQ3 2007 Alnylam Phar-1-1.3530.5530.0330.5529.831.451.73%1.73%691.40K
2007-08-09AMCQ2 2007 Alnylam Phar-0.24-0.3424.6325.9825.4624.4926.7-2.00%▲-3.26%-5.20%911.40K
2007-05-09Q1 2007 Alnylam Phar-0.28-0.5817.5619.3719.1617.1719.19-1.08%-8.35%-9.34%711.40K
2007-02-07Q4 2006 Alnylam Phar-0.3-0.2621.5921.521.6221.421.960.56%-0.14%0.42%396.70K
2006-11-02AMCQ3 2006 Alnylam Phar-0.33-0.2318.4819.0418.4517.7118.92-3.10%0.16%-2.94%648.10K
2006-07-26BMOQ2 2006 Alnylam Phar-0.28-0.3112.4412.612.812.0912.81.59%▲-2.81%-1.27%529.80K
2006-05-09AMCQ1 2006 Alnylam Phar-0.4-0.316.8516.1516.1516.116.954.33%4.33%370.20K
2006-02-15AMCQ4 2005 Alnylam Phar-0.5-0.5613.3513.5713.141313.47-3.17%1.60%-1.62%386.10K
2005-11-09AMCQ3 2005 Alnylam Phar-0.34-0.5110.4810.4810.6110.4410.691.24%-1.23%101.10K
2005-08-03AMCQ2 2005 Alnylam Phar-0.36-0.549.310.039.859.29.9-1.79%▲-5.58%-7.28%227.80K
2005-05-11AMCQ1 2005 Alnylam Phar-0.33-0.327.948.077.767.758.01-3.84%2.32%-1.61%45.20K
2004-11-10AMCQ3 2004 Alnylam Phar6.316.186.846.17.0410.68%-7.75%2.10%392.50K
2004-08-04AMCQ2 2004 Alnylam Phar5.235.255.265.235.260.19%▲-0.57%-0.38%7.30K

Login | Register
Sunday Jul 23, 2017   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY246.88-0.22-0.09%88,660,369

Upgrades/Downgrades